|
|
Anticoagulants - Adverse effects
Research News and Information
Definition of 'Anticoagulants'Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs. Common names: Anticoagulants; Anticoagulant Agents; Agents, Anticoagulant; Anticoagulant Drugs; Drugs, Anticoagulant |
Sunday, November 22, 2009
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review.
20 Dec 2009
We assessed the therapeutic efficacy and safety of laser prostatectomy (LP) for treating benign prostatic hyperplasia (BPH) in patients on oral anticoagulation. We systematically reviewed previous reports, using the Pubmed database and ... Read more...
[Anticoagulation during pregnancy following an artificial heart valve replacement]
4 Oct 2009
HISTORY AND CLINICAL FINDINGS: A 23-year-old woman had received a mechanical bileaflet mitral valve prosthesis because of severe mitral valve insufficiency caused by an acute bacterial endocarditis with vegetations. One year after the operation the ... Read more...
Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
3 Oct 2009
BACKGROUND: Patients with peripheral arterial disease are at high risk of ischemic events and therefore are treated with antithrombotics. In patients with coronary artery disease or cerebrovascular disease, bleeding is related to the subsequent ... Read more...
Latest indexed articles for 'Anticoagulants - Adverse effects'
These are the very latest articles for this heading:
- Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review.
20 Dec 2009 - Images in clinical medicine. Central nervous system hemorrhage.
27 Oct 2009 - [Anticoagulation during pregnancy following an artificial heart valve replacement]
4 Oct 2009 - Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
3 Oct 2009 - Development of universal antidotes to control aptamer activity.
2 Oct 2009 - The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?
29 Sep 2009 - Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
27 Sep 2009 - Incidence and causes of heparin-induced skin lesions.
26 Sep 2009 - Clopidogrel plus aspirin in atrial fibrillation.
22 Sep 2009 - Clopidogrel plus aspirin in atrial fibrillation.
22 Sep 2009 - [Stroke prevention in atrial fibrillation. Marcumar alternative in sight]
15 Sep 2009 - Vitamin K to correct overanticoagulation.
13 Sep 2009 - Vitamin K to correct overanticoagulation.
13 Sep 2009 - Vitamin K to correct overanticoagulation.
13 Sep 2009 - Vitamin K to correct overanticoagulation.
13 Sep 2009 - Vitamin K to correct overanticoagulation.
13 Sep 2009 - Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
9 Sep 2009 - The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation.
6 Sep 2009 - [Anticoagulation in atrial fibrillation. Stroke can be prevented this way]
Sep 2009 - Biomechanics/risk management (Working Group 2).
30 Aug 2009
See a longer list of these articles.
Technical information about 'Anticoagulants'
Definition: Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.
Registry Number: 0
Descriptor UI: D000925
Alternative terms: Anticoagulants; Anticoagulant Agents; Agents, Anticoagulant; Anticoagulant Drugs; Drugs, Anticoagulant;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D27.505.954.502.119;
Technical Notes: not for circulating natural anticoagulants; consider also BLOOD COAGULATION /drug eff & THROMBOSIS /drug ther or related dis with /drug ther; DF: ANTICOAG